MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.79
-0.25 (-2.26%)
At close: Nov 3, 2026, 4:00 PM EST
10.76
-0.03 (-0.28%)
After-hours: Nov 3, 2026, 7:34 PM EST
MiNK Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, MiNK Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $42.5. The average 1-year stock price forecast is 293.88% higher than the current stock price, while the lowest is $35 (+224.37%) and the highest is $50 (+363.39%).
Price Target: $42.5 (+293.88%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MiNK Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $43 → $50 | Buy | Maintains | $43 → $50 | +363.39% | Oct 21, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $35 | Buy | Reiterates | $35 | +224.37% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
1.90M
Revenue Next Year
2.75M
from 1.90M
Increased by 44.74%
EPS This Year
-2.21
from -2.93
EPS Next Year
-2.19
from -2.21
EPS and Forward PE are based on non-GAAP adjusted numbers.